These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 89884)

  • 1. Screening for open neural-tube defects in England and Wales.
    Wald N; Cuckle HS; Harwood CA
    Br Med J; 1979 Aug; 2(6185):331. PubMed ID: 89884
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal screening for neural tube defects.
    Holtzman NA
    Pediatrics; 1983 Apr; 71(4):658-60. PubMed ID: 6188096
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of screening for open neural tube defects in England and Wales.
    Cuckle H; Wald N
    Prenat Diagn; 1987 Feb; 7(2):91-9. PubMed ID: 2437555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New uncertainties in prenatal screening for neural tube defect.
    Harris R; Read AP
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1416-8. PubMed ID: 6164431
    [No Abstract]   [Full Text] [Related]  

  • 5. Maternal alpha-fetoprotein screening: two years' experience in a low-risk district.
    Standing SJ; Brindle MJ; Macdonald AP; Lacey RW
    Br Med J (Clin Res Ed); 1981 Sep; 283(6293):705-7. PubMed ID: 6169386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha fetoprotein in the antenatal diagnosis of open neural tube defects.
    Wald NJ; Cuckle HS
    Br J Hosp Med; 1980 May; 23(5):473-4, 476, 478-80 passim. PubMed ID: 6155962
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum alpha-feto protein screening for neural tube defects: some notes for programme evaluators.
    Mason ES; Clarke M
    J R Soc Health; 1986 Dec; 106(6):210-2. PubMed ID: 2433441
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for open neural tube defects from 21 to 25 weeks' gestation: the Manitoba experience.
    Björklund NK; MacDonald KM; Evans JA; Schneider CE; Chodirker BN
    Prenat Diagn; 2005 Aug; 25(8):715-7. PubMed ID: 16052469
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 10. Maternal serum alpha-fetoprotein screening: report of a pilot project in Iowa.
    Williamson RA; Hanson JW; Grant SS
    Iowa Med; 1986 Feb; 76(2):61-2, 63-4. PubMed ID: 2420743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Defects in neural tube closure in the Vaud canton 1980-1992. The impact of prenatal diagnosis].
    Marguerat P; Addor MC; Pescia G; Maillard-Brignon C; Laurini RN; Hohlfeld P; Vial Y; Weihs D
    Rev Med Suisse Romande; 1994 Oct; 114(10):851-9. PubMed ID: 7526434
    [No Abstract]   [Full Text] [Related]  

  • 12. The apparently declining prevalence of neural tube defect in two counties in South Wales over three decades illustrating the need for continuing action and vigilance.
    Laurence KM
    Z Kinderchir; 1985 Dec; 40 Suppl 1():58-60. PubMed ID: 2418600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal biochemical screening for neural tube defects.
    Muller F
    Childs Nerv Syst; 2003 Aug; 19(7-8):433-5. PubMed ID: 12861422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of a program for the prevention of neural tube defects].
    Kalmár Z; Czeizel E
    Orv Hetil; 1988 Jun; 129(23):1205-6, 1209-12. PubMed ID: 2453827
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for fetal neural tube defects: rationale and experience.
    Brock DJ
    Prog Clin Biol Res; 1982; 103 Pt B():461-72. PubMed ID: 6187021
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening model of studying alpha-foetoprotein of maternal serum (S-AFP) organized within central dispensary follow-up of pregnant women in Baranya region.
    Kóbor J; Pejtsik B; Pácsa S
    Sante Publique (Bucur); 1982; 25(3):193-9. PubMed ID: 6187074
    [No Abstract]   [Full Text] [Related]  

  • 17. Neural tube defects in New South Wales: management and preventive policies, 1965-1980.
    Field BR; Kerr CB
    Med J Aust; 1981 Dec 12-26; 2(12-13):667-70. PubMed ID: 6174849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The South Wales NTD screening experience.
    Bobrow M
    Lancet; 1983 Jul; 2(8343):222-3. PubMed ID: 6191166
    [No Abstract]   [Full Text] [Related]  

  • 19. Neural tube defects in Havana City--incidence and prenatal diagnosis.
    Rodriguez PL; Heredero B; Lopez J; Fernandez Yero JL; Oliva RJ
    Zentralbl Gynakol; 1982; 104(20):1325-7. PubMed ID: 6186106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.